Amgen Inc (AMGN) results explained: sales up 8%

Quantooo Lab · 2026-11-03

What happened?

Amgen Inc (AMGN) reported results on 3 Nov, covering the 9 months to 30 Sep.

The numbers in plain words

Sales were up 8.0% compared with the same period a year earlier. Out of every 100 of sales, about 34 was left after running costs (operating margin 34.1%), higher than a year earlier (23.7%). The company is funded less by borrowing than a year ago (85% of assets vs 89%).

Source: the company's 10-Q filed 2026-11-04.

How did the share price react?

Since the results, the share price has moved +2.80% (to the close of 4 Nov), while the S&P 500 moved +1.96%.

What changed in our score?

Our score went from 61 to 72 out of 100; the fundamentals part went from 75 to 77. Every step of the calculation: AMGN stock page.

How bumpy could the next month be?

Our volatility model expects the next month to be bumpier than usual for AMGN (27% a year vs a normal 25%).

What does it mean?

Results describe the past few months. They don't tell you where the price goes next, and our own tests found our scores don't reliably predict that either.

Educational, not investment advice.